GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
Piscataway, NJ, January 19, 2011 --(PR.com)-- GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world.
To an audience of primarily research scientists from both big pharma and academia, GE described the BiacoreTM T200’s excellent capabilities in label-free interaction analysis, while GenScript presented real life data the company just accomplished from several case studies, highlighting both the superiority of the equipment and the extraordinary service capabilities that GenScript can offer in the field of Antibody Engineering.
“Biacore is an expensive machine. We want to have the most advanced T200 model since it can further enhance our abilities on the examination of antibody and antigen affinity,” said Dr Oliver Zhang, Director of Antibody Engineering at GenScript. “We are offering Antibody Drug Development services with stable and unparalleled quality using high precision instrument like BiacoreTM T200.”
GenScript has established a comprehensive antibody drug development platform that can smoothly integrate antibody engineering and antibody production technologies to satisfy your need in drug development. GenScript's Antibody Drug Development Center, equipped with profound knowledge, extensive experience as well as state-of-the-art instruments, can provide superior services and products in the most time-efficient and cost-effective manner.
GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
###
For further information, please contact:
Sally Wang
Executive Vice President
GenScript USA Inc.
1-(732) 885-9188
Source: www.genscript.com
To an audience of primarily research scientists from both big pharma and academia, GE described the BiacoreTM T200’s excellent capabilities in label-free interaction analysis, while GenScript presented real life data the company just accomplished from several case studies, highlighting both the superiority of the equipment and the extraordinary service capabilities that GenScript can offer in the field of Antibody Engineering.
“Biacore is an expensive machine. We want to have the most advanced T200 model since it can further enhance our abilities on the examination of antibody and antigen affinity,” said Dr Oliver Zhang, Director of Antibody Engineering at GenScript. “We are offering Antibody Drug Development services with stable and unparalleled quality using high precision instrument like BiacoreTM T200.”
GenScript has established a comprehensive antibody drug development platform that can smoothly integrate antibody engineering and antibody production technologies to satisfy your need in drug development. GenScript's Antibody Drug Development Center, equipped with profound knowledge, extensive experience as well as state-of-the-art instruments, can provide superior services and products in the most time-efficient and cost-effective manner.
GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
###
For further information, please contact:
Sally Wang
Executive Vice President
GenScript USA Inc.
1-(732) 885-9188
Source: www.genscript.com
Contact
GenScript USA Inc.
Sally Wang
1-732- 885-9188
www.genscript.com
Sally Wang
1-732- 885-9188
www.genscript.com
Contact
Categories